GlassScriptPhysician profile
Lisa A Dructor
NPI 1245296169
$5,287.58
in general payments reported to CMS, 2019-2025
36 companies · $1,179 in 2025
The $1,179 reported for 2025 was more than what 87% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,028 · 2020: $133 · 2021: $336 · 2022: $1,346 · 2023: $616 · 2024: $649 · 2025: $1,179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,112 · Travel and Lodging: $256 · Education: $76.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,112.26 |
| Travel and Lodging | $255.50 |
| Education | $76.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $535.49 | 2022-2023 | Nuplazid |
| Bayer Healthcare Pharmaceuticals INC. | $506.59 | 2021-2025 | |
| Novo Nordisk INC | $491.89 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Astellas Pharma US INC | $487.43 | 2019-2025 | Veozah |
| Cook Medical LLC | $407.49 | 2025 | Zenith Spiral-Z |
| Janssen Pharmaceuticals, INC | $406.02 | 2019 | |
| Lilly USA, LLC | $290.11 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Boston Scientific Corporation | $261.30 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $230.20 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Biohaven Pharmaceutical Holding Company LTD. | $161.89 | 2022 | |
| Abbvie INC. | $152.02 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $131.55 | 2019-2022 | |
| Corcept Therapeutics | $125.12 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $115.04 | 2024-2025 | Xifaxan |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $98.75 | 2019 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $96.40 | 2019-2020 | |
| Glaxosmithkline, LLC. | $92.40 | 2024-2025 | Trelegy Ellipta, Arexvy |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $68.96 | 2025 | Caplyta |
| Exact Sciences Corporation | $65.94 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $64.22 | 2023-2025 | Gemtesa |
| Amgen INC. | $64.11 | 2025 | Repatha, Otezla |
| Catalyst Pharmaceuticals, INC. | $59.95 | 2023-2024 | Fycompa |
| Sanofi-Aventis U.S. LLC | $53.49 | 2024-2025 | |
| Amarin Pharma, INC. | $53.10 | 2019 | |
| Medtronic, INC. | $50.91 | 2022-2024 | Minimed 780g |
| Xeris Pharmaceuticals, INC. | $49.02 | 2022-2024 | Recorlev, Gvoke Hypopen |
| Philips North America LLC | $30.61 | 2022 | |
| Shield Therapeutics INC | $27.45 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $15.82 | 2025 | Austedo Xr |
| Optos, INC. | $14.96 | 2020 | |
| Esperion Therapeutics, INC. | $14.93 | 2023 | Nexletol |
| Paratek Pharmaceuticals, INC. | $14.57 | 2025 | Nuzyra |
| Pfizer INC. | $13.72 | 2023 | |
| Horizon Therapeutics Plc | $12.14 | 2019 | |
| Allergan, INC. | $12.00 | 2020 | |
| Avanir Pharmaceuticals, INC. | $11.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Dructor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.